Hjem
Karl Henning Kallands bilde

Karl Henning Kalland

Professor
  • E-postKalland@uib.no
  • Telefon+47 55 58 45 06
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) 2021. Evaluation of β-catenin inhibition of axitinib and nitazoxanide in human monocyte-derived dendritic cells. Biomedicines. 1-18.
  • Vis forfatter(e) 2020. Dual pro- and anti-inflammatory features of monocyte-derived dendritic cells. Frontiers in Immunology. 1-15.
  • Vis forfatter(e) 2019. PIK3CA amplification associates with aggressive phenotype but not markers of AKT-mTOR signaling in endometrial carcinoma. Clinical Cancer Research. 334-345.
  • Vis forfatter(e) 2018. Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer. Nature Chemical Biology. 94-101.
  • Vis forfatter(e) 2018. Screening for viral nucleic acids in vestibular schwannoma. Journal of Neurovirology. 730-737.
  • Vis forfatter(e) 2018. Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. PLOS ONE. 1-21.
  • Vis forfatter(e) 2018. Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino-terminal domain. Pharmacology Research & Perspectives. 1-15.
  • Vis forfatter(e) 2017. Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts. BMC Cancer. 1-13.
  • Vis forfatter(e) 2017. Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. OncoTarget. 106989-107001.
  • Vis forfatter(e) 2017. PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. Scientific Reports. 1-12.
  • Vis forfatter(e) 2017. HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. British Journal of Cancer. 378-387.
  • Vis forfatter(e) 2017. An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells. PLOS ONE. 1-20.
  • Vis forfatter(e) 2016. Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes. BMC Cancer. 17 sider.
  • Vis forfatter(e) 2016. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes. BMC Cancer. 15 sider.
  • Vis forfatter(e) 2016. Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer. Proceedings of the National Academy of Sciences of the United States of America. 9339-9344.
  • Vis forfatter(e) 2016. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. OncoTarget. 9696-9707.
  • Vis forfatter(e) 2016. Androgen receptor as potential therapeutic target in metastatic endometrial cancer. OncoTarget. 49289-49298.
  • Vis forfatter(e) 2015. Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. OncoTarget. 39676-39691.
  • Vis forfatter(e) 2015. Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. OncoTarget. 1327-1339.
  • Vis forfatter(e) 2015. Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. OncoTarget. 10634-10645.
  • Vis forfatter(e) 2015. ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. OncoTarget. 28440-28452.
  • Vis forfatter(e) 2014. Switch in FOXA1 status associates with endometrial cancer progression. PLOS ONE.
  • Vis forfatter(e) 2014. Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors. Molecular Cancer Research. 754-764.
  • Vis forfatter(e) 2014. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. OncoTarget. 1052-1061.
  • Vis forfatter(e) 2014. High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. British Journal of Cancer. 78-84.
  • Vis forfatter(e) 2014. Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. Gynecologic Oncology. 599-606.
  • Vis forfatter(e) 2013. p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model. PLOS ONE. 12 sider.
  • Vis forfatter(e) 2013. MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. International Journal of Cancer. 544-555.
  • Vis forfatter(e) 2013. Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. Clinical Cancer Research. 1094-1105.
  • Vis forfatter(e) 2013. Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. PLOS ONE. 9 sider.
  • Vis forfatter(e) 2013. High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. Clinical Cancer Research. 2331-2341.
  • Vis forfatter(e) 2013. Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling. Cancer Research. 7090-7100.
  • Vis forfatter(e) 2013. Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model. PLOS ONE. 11 sider.
  • Vis forfatter(e) 2013. Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients. Cell Proliferation. 554-562.
  • Vis forfatter(e) 2013. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. Modern Pathology. 428-434.
  • Vis forfatter(e) 2012. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 8699-8704.
  • Vis forfatter(e) 2012. Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. British Journal of Cancer. 1682-1688.
  • Vis forfatter(e) 2012. Lipocalin 2 expression is associated with aggressive features of endometrial cancer. BMC Cancer. 7 sider.
  • Vis forfatter(e) 2012. KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. British Journal of Cancer. 1997-2004.
  • Vis forfatter(e) 2012. High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. PLOS ONE.
  • Vis forfatter(e) 2012. Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. BMC Cancer. 10 sider.
  • Vis forfatter(e) 2011. Transcribed DNA is preferentially located in the perichromatin region of mammalian cell nuclei. Experimental Cell Research. 433-444.
  • Vis forfatter(e) 2011. Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. Experimental Cell Research. 234-247.
  • Vis forfatter(e) 2011. High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. British Journal of Cancer. 921-926.
  • Vis forfatter(e) 2011. Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial Cancer. American Journal of Pathology. 861-871.
  • Vis forfatter(e) 2011. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PLOS ONE. 15 sider.
  • Vis forfatter(e) 2010. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation. European Journal of Haematology. 239-251.
  • Vis forfatter(e) 2010. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomics. 15 sider.
  • Vis forfatter(e) 2009. TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis. APMIS - Journal of Pathologiy, Microbiology and Immunology. 575-582.
  • Vis forfatter(e) 2009. Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators. British Journal of Haematology. 53-68.
  • Vis forfatter(e) 2009. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors; release profile and pharmacological modulaion. European Journal of Haematology. 239-251.
  • Vis forfatter(e) 2009. Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia. British Journal of Haematology. 53-68.
  • Vis forfatter(e) 2009. Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proceedings of the National Academy of Sciences of the United States of America. 4834-4839.
  • Vis forfatter(e) 2009. Hyperoxic treatment induces mesenchymal to epithelial transition in a rat adenocarcinoma model. PLOS ONE.
  • Vis forfatter(e) 2009. Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype. Neuropathology and Applied Neurobiology. 380-393.
  • Vis forfatter(e) 2009. Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLOS ONE. 14 sider.
  • Vis forfatter(e) 2009. Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia. BMC Cancer.
  • Vis forfatter(e) 2009. Cytokines are produced locally by myocytes in rat skeletal muscle during endotoxemia. American Journal of Physiology. Heart and Circulatory Physiology. H735-H744.
  • Vis forfatter(e) 2008. WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence. Clinical Cancer Research. 1397-1406.
  • Vis forfatter(e) 2008. Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels. Leukemia. 287-293.
  • Vis forfatter(e) 2008. Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. British Journal of Cancer. 1662-1669.
  • Vis forfatter(e) 2008. Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation. PLOS ONE.
  • Vis forfatter(e) 2007. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica. 332-341.
  • Vis forfatter(e) 2007. Increased expression of sim2-s protein is a novel marker of aggressive prostate cancer. Clinical Cancer Research. 892-897.
  • Vis forfatter(e) 2007. Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. Journal of Neuro-Oncology. 191-202.
  • Vis forfatter(e) 2007. Functional characteristics and gene expression profiles of primary acute myeloid leukamia cells indentify patient subgroups that differ susceptibility to histone deactylase inhibitors. International Journal of Oncology. 1529-1538.
  • Vis forfatter(e) 2007. ERG upregulation and related ETS transcription factors in prostate cancer. International Journal of Oncology. 19-32.
  • Vis forfatter(e) 2007. Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization. Analytical Biochemistry. 46-58.
  • Vis forfatter(e) 2006. cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. International Journal of Oncology. 1065-1080.
  • Vis forfatter(e) 2006. Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2 : Bax ratio and low levels of heat shock protein 70 and 90. Leukemia Research. 1531-1540.
  • Vis forfatter(e) 2006. Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 16466-16471.
  • Vis forfatter(e) 2006. A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. Clinical Cancer Research. 3985-3992.
  • Vis forfatter(e) 2005. Nucleic-acid based diagnostics in clinical microbiology. Tidsskrift for Den norske legeforening. 3110-3114.
  • Vis forfatter(e) 2005. Gene expression profiles in prostate cancer: Association with patient subgroups and tumour differentiation. International Journal of Oncology. 329-336.
  • Vis forfatter(e) 2005. CD34 expression in native human acute myelogenous leukemia blasts: Differences in CD34 membrane molecule expression are associated with different gene expression profiles. Cytometry. 18-27.
  • Vis forfatter(e) 2003. Cellular localisation and nuclear export of the human bZIP transcription factor TCF11. Biochimica et Biophysica Acta. 143-151.
  • Vis forfatter(e) 2002. Rev inhibition strongly affects intracellular distribution of HIV-1 RNAs. Journal of Virology. 10473-10484.
  • Vis forfatter(e) 2002. Nuclear import of factors involved in signaling is inhibited in C3H/10T1/2 cells treated with tetradecylthioacetic acid. Journal of Lipid Research. 1630-1640.
  • Vis forfatter(e) 2002. Analysis of acute myelogenous leukemia: preparation of samples for genomic and proteomic analyses. Journal of Hematotherapy & Stem Cell Research. 469-481.
  • Vis forfatter(e) 2001. Mitochondrial protein p32 can accumulate in the nucleus. Biochemical and Biophysical Research Communications - BBRC. 1161-1169.
  • Vis forfatter(e) 2000. Identification of a nuclear ribonucleoprotein particle which contains incompletely spliced HIV-1 RNAs. Biochemical and Biophysical Research Communications - BBRC. 509-513.
  • Vis forfatter(e) 1999. Nukleinsyrebasert mikrobiolgoisk diagnostikk. Tidsskrift for Den norske legeforening. 802-809.
  • Vis forfatter(e) 1999. Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs. Journal of General Virology. 1965-1974.
  • Vis forfatter(e) 1999. A trans-dominant negative mutant of the HIV-1 Rev protein affects the Rev-dependent splicing pattern and expression of HIV RNA. Journal of General Virology. 1965-1974.
  • Vis forfatter(e) 1998. Visualisation of ribosomal RNA (rRNA) synthesis in eukaryotic cells in culture. Methods in Cell Science. 295-302.
  • Vis forfatter(e) 1998. Subcellular localization of human immunodeficiency virus type 1 RNAs, Rev, and the splicing factor SC-35. Virology. 473-482.
  • Vis forfatter(e) 1998. Labelling of eukaryotic RNA transcripts with BrUTP using liposomal (DOTAP) and non-liposomal (FuGENE 6) transfection reagents: new application for transfection reagents. Biochemica. 45-46.
  • Vis forfatter(e) 1998. Histographic recording of human immunodeficiency virus type 1 (HIV-1) regulatory protein Rev and nuclear factors. APMIS - Journal of Pathologiy, Microbiology and Immunology. 623-635.
  • Vis forfatter(e) 1997. Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import. Virology. 73-81.
  • Vis forfatter(e) 1997. Labelling of RNA transcripts of eukaryotic cells in culture with Br UTP using a liposome transfection reagent (DOTAP). BioTechniques. 308-312.
  • Vis forfatter(e) 1996. Immunoglobin G sublass antibodies to rubella viruses in chronic liver disease, acute rubella and healthy controls. FEMS Immunology and Medical Microbiology. 43-50.
  • Vis forfatter(e) 1996. HIV-1 proviral DNA sequences of env PCR amplificates from Tanzania. APMIS - Journal of Pathologiy, Microbiology and Immunology. 459-464.
  • Vis forfatter(e) 1995. Raised levels of antibodies to human viruses at the clinical onset of autoimmune chronic active hepatitis. Journal of Viral Hepatitis. 159-164.
  • Vis forfatter(e) 1995. Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. Journal of Virology. 3315-3323.
  • Vis forfatter(e) 1994. Viral antibodies in infectious mononucleosis. FEMS Immunology and Medical Microbiology. 219-224.
  • Vis forfatter(e) 1994. Radioimmunoprecipitation and immunoblot studies of antibodies to rubella virus in patients with chronic liver disease. Archives of Virology. 73-85.
  • Vis forfatter(e) 1994. Elevated rubella antibodies in patients with chronic liver diseases. Journal of Medical Virology. 30-36.
  • Vis forfatter(e) 1993. Diagnosis of infection with human T-cell lymphotropic virus type 2 (HTL V-2) in Norwegian HIV infected individuals. Clinical and Diagnostic Virology. 143-152.
  • Vis forfatter(e) 1991. Viral RNA species in cell lines persistently and lytically infected with measles virus. APMIS - Journal of Pathologiy, Microbiology and Immunology. 42-48.
  • Vis forfatter(e) 1991. Study of transcription in measles virus infected Vero cells using cDNA probes prepared from poly(A)RNA from uninfected and infected cells. APMIS - Journal of Pathologiy, Microbiology and Immunology. 33-41.
  • Vis forfatter(e) 1991. Rex-dependent nucleolar accumulation of HTLV-1 mRNA. The New Biologist. 389-397.
  • Vis forfatter(e) 1991. Replication of HIV-1 in primary dendritic cell cultures. Proceedings of the National Academy of Sciences of the United States of America. 7998-8002.
  • Vis forfatter(e) 1991. Presence of cfaD-homologous sequences and expression of coli surface antigen 4 on enterotoxigenic Escherichia coli; relevance for diagnostic procedures. Microbial Pathogenesis. 297-304.
  • Vis forfatter(e) 1990. Applications of Magnetic Beads With Covalently Attached Oligonucleotides in Hybridization: Isolation and Detection of Specific Measles Virus mRNA from Crude Cell Lysate. Analytical Biochemistry. 40-50.
  • Vis forfatter(e) 1989. Mechanism of spontaneous loss of heat-stable toxin (STa) Production in enterotoxigenic Escherichia coli. APMIS - Journal of Pathologiy, Microbiology and Immunology. 436-440.
  • Vis forfatter(e) 1988. Comparative Study of Colony Hybridization With Synthetic Oligonucleotide Probes and Enzyme-Linked Immunosorbent Assay for Identification of Enterotoxigenic Escherichia Coli. Journal of Clinical Microbiology. 530-534.
Populærvitenskapelig foredrag
  • Vis forfatter(e) 2007. Virus og kreft.
  • Vis forfatter(e) 2005. Overexpression of ERG and SIM2 transcription factors in prostate cancer.
Vitenskapelig foredrag
  • Vis forfatter(e) 2009. Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
  • Vis forfatter(e) 2009. EMT Promotes Malignant Transformation of Prostate Epithelial Cells in Culture.
  • Vis forfatter(e) 2009. A novel cell culture model of prostate carcinogenesis and its utility in phenotypic screening of small molecular compounds.
  • Vis forfatter(e) 2008. Targeting master regulatory mechanisms in cancer therapy using novel small molecular compounds – basic mechanisms, in vitro and in vivo screening and development towards the clinic.
  • Vis forfatter(e) 2008. Regulatory patterns of prostate carcinogenesis and development of a cell culture experimental system.
  • Vis forfatter(e) 2008. Polycomb group target genes and bivalent H3K4 & K27me3 modifications in human embryonic cells were enriched among dysregulated genes in prostate cancer.
  • Vis forfatter(e) 2008. Epithelial to mesenchymal transition of a primary, immortalized prostate cell line is associated with gene expression switches of entire cell attachment modules.
  • Vis forfatter(e) 2007. Functional oncogenomics and epigenomics analysis of prostate cancer.
  • Vis forfatter(e) 2007. Detection of TMPRSS2:ERG translocations in the urine of prostate cancer patients and identification of ERG target genes.
  • Vis forfatter(e) 2006. The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy.
  • Vis forfatter(e) 2006. The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy.
  • Vis forfatter(e) 2006. Global gene expression analysis of transcription factors in prostate cancer and cell lines.
  • Vis forfatter(e) 2006. ERG upregulation in relation to other transcription factors in prostate cancer.
  • Vis forfatter(e) 2006. ERG upregulation and related transcription factors in prostate cancer.
  • Vis forfatter(e) 2005. Overexpression of ERG and SIM2 transcription factors in prostate cancer.
  • Vis forfatter(e) 2005. Onkogene, hepatotrope virus – molekylære mekanismer ved utvikling av hepatocellulært carcinom (HCC).
  • Vis forfatter(e) 2005. Nuclear localization of active genes and their transcripts.
  • Vis forfatter(e) 2005. Discovering candidate genes that distinguish between CML and AML using microarrays.
  • Vis forfatter(e) 2004. Virus and cancer models.
  • Vis forfatter(e) 2004. Real time quantitative PCR and hepatitis C monitoring.
  • Vis forfatter(e) 2004. Global analysis of gene expression and regulatory modules in cancer tissue.
  • Vis forfatter(e) 2004. Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue.
  • Vis forfatter(e) 2004. Gene expression profiles in prostate cancer: identification of upregulated SIM2 gene validated in archival tissue, relation to histological grading and prognosis.
  • Vis forfatter(e) 2003. Virus og Cancer.
  • Vis forfatter(e) 2003. Global analysis of gene expression and regulatory patterns in urogenital tumours using DNA microarrays.
  • Vis forfatter(e) 2003. Global analysis of gene expression and regulatory patterns in cancer.
  • Vis forfatter(e) 2003. Global analysis of gene expression and regulatory patterns in acute myeloid leukemia.
  • Vis forfatter(e) 2003. Gene expression profiling in prostate cancer: cluster analysis and association with tumor differentation.
  • Vis forfatter(e) 2003. Gene expression profiling in prostate cancer.
  • Vis forfatter(e) 2003. Comparison of DNA microarray and real time quantitative PCR for quantitation of gene expression of selected genes in prostate cancer.
  • Vis forfatter(e) 2001. Global gene expression profiling using DNA microarrays - pitfalls and outlook.
  • Vis forfatter(e) 2001. Global analysis of gene expression in human cancer.
  • Vis forfatter(e) 2001. Angiostatin release from alginate encapsulated 293-cells.
Anmeldelse
  • Vis forfatter(e) 2007. Immunologiske refleksjonar - "Defending Life" av Elling Ulvestad, London - Springer forlag ISBN 978-1-4020-5675-8. Tidsskrift for Den norske legeforening. 3298-3299.
Fagbok
  • Vis forfatter(e) 1991. Kompendium i virologi. [Mangler utgivernavn].
  • Vis forfatter(e) 1989. Southeast Asia between Autocracy and Democracy. Aarhus Universitetsforlag.
Populærvitenskapelig artikkel
  • Vis forfatter(e) 1998. HIV som modellsystem til forståing av genekspresjon. Naturen. 67-77.
Kronikk
  • Vis forfatter(e) 1993. HTLV-I-infeksjon i Norge. Natl Inst Publ Health Rep (MSIS).
Doktorgradsavhandling
  • Vis forfatter(e) 2018. Regulatory patterns in prostate cell differentiation – investigation of transcription factors AR, GATA2 and NKX3-1.
  • Vis forfatter(e) 2017. Context dependent transcription factor regulation in normal and malignant cell differentiation.
  • Vis forfatter(e) 1989. Studies on measles virus in lytic and persistent infections ; Construction and use of measles virus specific nucleic acid probes.
Intervju
  • Vis forfatter(e) 2013. Til hjelp for andre i 40 år - Tordis og Fritz C. Riebers legat 1973 - 2013.
  • Vis forfatter(e) 2013. Skreddersyr medisiner mot kreft.
  • Vis forfatter(e) 2013. Omprogrammerer celler - utforsker nye angrepsmål ved prostatakreft.
  • Vis forfatter(e) 2013. Legat-jubileum: midler til kreftforskning.
  • Vis forfatter(e) 2008. Verdens Gang - Professorat betalt av GlaxoSmithKline ved Universitetet i Bergen.
  • Vis forfatter(e) 2008. Bergens Tidende - Vil ha DNA-lab i Bergen.
  • Vis forfatter(e) 2007. Livmorhalskreft.
  • Vis forfatter(e) 2005. Legionella og andre bakterier.
  • Vis forfatter(e) 2005. Gades Institutt - presentasjon.
  • Vis forfatter(e) 2005. Gades Institutt - presentasjon.
  • Vis forfatter(e) 2003. Bakterier og virus - slik beskytter du deg.
  • Vis forfatter(e) 2001. Bakterier og virus.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • Vis forfatter(e) 2017. Models of Tumor Progression in Prostate Cancer. 16 sider.
  • Vis forfatter(e) 2009. Molecular Microbiological Diagnostics.
  • Vis forfatter(e) 1998. Mikrobiologisk diagnostikk. Kapittel om Nukleinsyrebasert diagnostikk.
  • Vis forfatter(e) 1991. Retroviral regulatory proteins and the nucleolus. 14 sider.
  • Vis forfatter(e) 1991. HIV-1 infection of human dendritic cells. 15 sider.
Sammendrag/abstract
  • Vis forfatter(e) 2013. FOXA1 LOSS IN ENDOMETRIAL CANCER IS ASSOCIATED WITH POOR PROGNOSIS AND ER ALPHA LOSS. International Journal of Gynecological Cancer. 1 sider.
  • Vis forfatter(e) 2012. Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. Virchows Archiv. S18-S18.
  • Vis forfatter(e) 2011. TUMOR-ASSOCIATED GLIAL CELLS PROMOTE GROWTH OF GBM XENOGRAFTS IN EGFP NOD/SCID MICE. Neuro-Oncology. 55-55.
  • Vis forfatter(e) 2009. PRIMARY HUMAN ACUTE MYELOGENOUS LEUKEMIA CELLS SHOW CONSTITUTIVE RELEASE OF SEVERAL MATRIX METALLOPROTEASES AND THEIR INHIBITORS. Haematologica. 545-545.
  • Vis forfatter(e) 2007. Release of angiopoietin-1 by acute myelogenous leukemia (AML) cells is increased by stromal cells and associated with mutations in the nucleophosmin (NPM) gene. Experimental Hematology. 72-72.
  • Vis forfatter(e) 2007. Linking susceptibility to histone deactylase inhibitors and basal gene expression profiles in acute myeloid leukaemia. Experimental Hematology. 77-77.
  • Vis forfatter(e) 2007. Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in the susceptibility to histone deacetylase inhibitors. Haematologica. 112-112.
  • Vis forfatter(e) 2006. cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. NBS-nytt. 106.
  • Vis forfatter(e) 2006. The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy. International Journal of Molecular Medicine. S65.
  • Vis forfatter(e) 2006. Global gene expression analysis of transcription factors in prostate cancer and cell lines. International Journal of Molecular Medicine. S27.
  • Vis forfatter(e) 2006. ERG upregulation in relation to other transcription factors in prostate cancer. NBS-nytt. 72.
  • Vis forfatter(e) 2005. Single-minded 2 homolog gene is overexpressed in prostate cancer. Virchows Archiv. 432-432.
  • Vis forfatter(e) 2005. Overexpression of ERG and SIM2 transcription factors in prostate cancer. International Journal of Molecular Medicine. S76-S76.
Poster
  • Vis forfatter(e) 2013. TP63 regulation of EMT in an experimental prostate cell model.
  • Vis forfatter(e) 2013. Reactive oxygen species induce prostate cancer cells via activation of the IL6/STAT3 pathway. Abstract 304.
  • Vis forfatter(e) 2009. Suppression of heat shock Protein 27 induces long-term dormancy in human breast cancer.
  • Vis forfatter(e) 2009. Stepwise prostate carcinogenesis in vitro culture.
  • Vis forfatter(e) 2009. Stathmin is superior to AKT and Phospho-AKT staining to detect PI3Kinase activation and aggressive endometrial cancer.
  • Vis forfatter(e) 2009. Hyperoxic Treatment induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model.
  • Vis forfatter(e) 2009. Highly infiltrative brain tumors show reduced chemosensitivity associated with a stem cell-like phenotype.
  • Vis forfatter(e) 2009. Global profiling of histone and DNA methylation reveals epigenetic-based gene regulation during EMT and transformation in a prostate cell model.
  • Vis forfatter(e) 2009. Global profiling of histone and DNA methylation reveals epigenetic-based gene regulation during EMT and transformation in a prostate cell model.
  • Vis forfatter(e) 2009. Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
  • Vis forfatter(e) 2009. Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
  • Vis forfatter(e) 2009. Epithelial to mesenchymal transition of a primary prostate cell line before malignant transformation with switches of cell adhesion modules.
  • Vis forfatter(e) 2009. A novel model of stepwise prostate carcinogenesis in culture.
  • Vis forfatter(e) 2007. Detection of TMPRSS2:ERG translocations in the urine of prostate cancer patients.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) 2021. Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System . Cancers.
  • Vis forfatter(e) 2018. Targeting Wnt/β-catenin signaling for cancer immunotherapy. TIPS - Trends in Pharmacological Sciences. 648-658.
  • Vis forfatter(e) 2009. Tumor virology - history, status and future challenges. APMIS - Journal of Pathologiy, Microbiology and Immunology. 382-399.
  • Vis forfatter(e) 2007. Global gene expression in classification, pathogenetic understanding and identification of therapeutic targets in Acute Myeloid Leukemia. Current Pharmaceutical Biotechnology. 344-354.
  • Vis forfatter(e) 2007. Early gene expression of acute myeloid leukemia in response to chemotherapy. Expert Review of Anticancer Therapy. 741-751.
Faglig kapittel
  • Vis forfatter(e) 2019. Hepatittvirus. 340-344. I:
    • Vis forfatter(e) 2019. Medisinsk mikrobiologi. Gyldendal Akademisk.
  • Vis forfatter(e) 2009. Molecular microbial diagnostics. 336-364. I:
    • Vis forfatter(e) 2009. Molecular Biology and Biotechnology 5th Ed. Springer.

Se fullstendig oversikt over publikasjoner i CRIStin.

Forskergrupper